secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2026-08-28T10:45:27+00:00
Accession:  0001829126-26-009454
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO receives Nasdaq delisting notice for bid price below $1.00
-------------------------------------------------------------------

- On Aug 27, 2026, Nasdaq notified KALA that bid price was below $1.00 for 30 consecutive business days (Jul 16–Aug 26, 2026).
- Company ineligible for 180-day compliance period due to 1-for-50 reverse stock split effected May 11, 2026.
- KALA intends to timely request a hearing before the Nasdaq Hearings Panel to appeal the determination.
- A timely hearing request stays suspension or delisting pending the Panel's decision; no assurance of continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626009454/0001829126-26-009454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000182912626009454/kalabio_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-009454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer